STMicroelectronics introduces Medical-grade motion sensors to accelerate the development of implantable medical applications

     STMicroelectronics, a leading global supplier of semiconductors across multiple electronics applications, has launched applications for the U.S. Food and Drug Administration (FDA), U.S. Food and Drug Administration's MIS2DH Medical dedicated ultra-low power 3-axis accelerometer for tertiary implantable medical device applications. For many years, ST has developed custom motion sensors for the world's leading medical device manufacturers. The new product MIS2DH translates years of experience and knowledge into a ready-to-use solution that helps users integrate functions such as activity monitoring and posture sensing into a variety of medical applications.

     Over the years, cardiac pacemaker, implantable cardioverter defibrillator (ICD), Implantable Cardioverter defibrillators, neurostimulators and other implantable medical devices have successfully extended the lives of patients with heart disease and greatly improved the quality of life of patients with chronic angina. Today, the medical community is beginning to explore the use of implantable medical devices to adjunct the treatment of patients with other chronic diseases, such as hypertension, epilepsy, or tremor. Embedded accelerometers with patient activity measurement and posture sensing capabilities are important for most medical applications that manage the stimulus response generated by implantable devices to improve treatment outcomes and patient quality of life.

     Until now, innovative medical devices developed by many smes have had to overcome two major obstacles: the high cost of designing customized sensors; The other is to obtain FDA certification. The MIS2DH accelerometer was developed in full compliance with ST's product regulations for Medical applications. St introduced internal self-regulation in 2012 to ensure the safety of the research and development process for sensitive medical products.

     Anton Hofmeister, General Manager of STMicroelectronics Custom MEMS Products Department, said: "Regardless of the size of the enterprise, medical researchers and electronics technologists want to explore how implantable devices can help patients with chronic diseases improve their quality of life or extend their lifespan, and this research becomes increasingly urgent as the world ages." "St has made significant progress in this area of research and development, and our solutions are world-leading motion sensor technology combined with a development, manufacturing and testing process designed to meet the most stringent medical regulations to reduce costs and accelerate time-to-market."